Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | ISO | Gapvd1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of GAPVD1 mRNA | CTD | PMID:36331819 | 1,2-dimethylhydrazine | multiple interactions | ISO | Gapvd1 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GAPVD1 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | decreases expression | ISO | Gapvd1 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of GAPVD1 mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of GAPVD1 mRNA | CTD | PMID:29097150 | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | ISO | GAPVD1 (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:31675489 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Gapvd1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of GAPVD1 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GAPVD1 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GAPVD1 mRNA | CTD | PMID:34747641 | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 4-dinitrotoluene affects the expression of GAPVD1 mRNA | CTD | PMID:21346803 | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 6-dinitrotoluene affects the expression of GAPVD1 mRNA | CTD | PMID:21346803 | 2-hydroxypropanoic acid | decreases expression | ISO | GAPVD1 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of GAPVD1 mRNA | CTD | PMID:30851411 | acrolein | multiple interactions | ISO | GAPVD1 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of GAPVD1 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of GAPVD1 mRNA | CTD | PMID:32699268 | aflatoxin B1 | increases expression | ISO | Gapvd1 (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of GAPVD1 mRNA | CTD | PMID:19770486 | Aflatoxin B2 alpha | decreases methylation | ISO | GAPVD1 (Homo sapiens) | 6480464 | aflatoxin B2 results in decreased methylation of GAPVD1 intron | CTD | PMID:30157460 | alpha-pinene | multiple interactions | ISO | GAPVD1 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of GAPVD1 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of GAPVD1 mRNA | CTD | PMID:32699268 | Aroclor 1254 | decreases expression | ISO | Gapvd1 (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of GAPVD1 mRNA | CTD | PMID:23650126 | arsenite(3-) | multiple interactions | ISO | GAPVD1 (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to GAPVD1 mRNA] | CTD | PMID:32406909 | atrazine | decreases expression | ISO | GAPVD1 (Homo sapiens) | 6480464 | Atrazine results in decreased expression of GAPVD1 mRNA | CTD | PMID:22378314 | benzo[a]pyrene | increases expression | ISO | Gapvd1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of GAPVD1 mRNA | CTD | PMID:22228805 | benzo[a]pyrene | affects methylation | ISO | GAPVD1 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of GAPVD1 intron | CTD | PMID:30157460 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | GAPVD1 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 and PMID:20018196 | benzo[e]pyrene | decreases methylation | ISO | GAPVD1 (Homo sapiens) | 6480464 | benzo(e)pyrene results in decreased methylation of GAPVD1 intron | CTD | PMID:30157460 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of GAPVD1 mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | ISO | GAPVD1 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of GAPVD1 protein | CTD | PMID:37567409 | bisphenol A | decreases expression | ISO | GAPVD1 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of GAPVD1 protein | CTD | PMID:31675489 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of GAPVD1 mRNA | CTD | PMID:30816183 | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of GAPVD1 mRNA | CTD | PMID:33453195 | caffeine | affects phosphorylation | ISO | GAPVD1 (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of GAPVD1 protein | CTD | PMID:35688186 | chloroprene | increases expression | EXP | | 6480464 | Chloroprene results in increased expression of GAPVD1 mRNA | CTD | PMID:23125180 | chlorpyrifos | decreases expression | ISO | Gapvd1 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of GAPVD1 mRNA | CTD | PMID:37019170 | cisplatin | decreases phosphorylation | ISO | Gapvd1 (Mus musculus) | 6480464 | Cisplatin results in decreased phosphorylation of GAPVD1 protein | CTD | PMID:22006019 | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of GAPVD1 mRNA | CTD | PMID:21266533 | diethylstilbestrol | increases expression | ISO | GAPVD1 (Homo sapiens) | 6480464 | Diethylstilbestrol results in increased expression of GAPVD1 mRNA | CTD | PMID:36621641 | enzyme inhibitor | multiple interactions | ISO | GAPVD1 (Homo sapiens) | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of GAPVD1 protein | CTD | PMID:23301498 | ethanol | multiple interactions | ISO | Gapvd1 (Mus musculus) | 6480464 | Ethanol affects the expression of and affects the splicing of GAPVD1 mRNA | CTD | PMID:30319688 | fenthion | decreases expression | ISO | Gapvd1 (Mus musculus) | 6480464 | Fenthion results in decreased expression of GAPVD1 mRNA | CTD | PMID:34813904 | folic acid | multiple interactions | ISO | Gapvd1 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GAPVD1 mRNA | CTD | PMID:22206623 | FR900359 | affects phosphorylation | ISO | GAPVD1 (Homo sapiens) | 6480464 | FR900359 affects the phosphorylation of GAPVD1 protein | CTD | PMID:37730182 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of GAPVD1 mRNA | CTD | PMID:33387578 | hydrogen peroxide | multiple interactions | ISO | Gapvd1 (Mus musculus) | 6480464 | [Hydrogen Peroxide co-treated with N-(oxo-5 more ... | CTD | PMID:31494107 | ivermectin | decreases expression | ISO | GAPVD1 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of GAPVD1 protein | CTD | PMID:32959892 | methapyrilene | decreases methylation | ISO | GAPVD1 (Homo sapiens) | 6480464 | Methapyrilene results in decreased methylation of GAPVD1 intron | CTD | PMID:30157460 | methidathion | decreases expression | ISO | Gapvd1 (Mus musculus) | 6480464 | methidathion results in decreased expression of GAPVD1 mRNA | CTD | PMID:34813904 | methotrexate | increases expression | ISO | GAPVD1 (Homo sapiens) | 6480464 | Methotrexate results in increased expression of GAPVD1 mRNA | CTD | PMID:24449571 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of GAPVD1 mRNA | CTD | PMID:25729387 | ozone | multiple interactions | ISO | GAPVD1 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of GAPVD1 mRNA more ... | CTD | PMID:32699268 | paracetamol | affects expression | ISO | Gapvd1 (Mus musculus) | 6480464 | Acetaminophen affects the expression of GAPVD1 mRNA | CTD | PMID:17562736 | perfluorohexanesulfonic acid | decreases expression | ISO | Gapvd1 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in decreased expression of GAPVD1 mRNA | CTD | PMID:37995155 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Gapvd1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of GAPVD1 mRNA | CTD | PMID:36331819 | phenobarbital | affects expression | ISO | Gapvd1 (Mus musculus) | 6480464 | Phenobarbital affects the expression of GAPVD1 mRNA | CTD | PMID:23091169 | propiconazole | decreases expression | ISO | Gapvd1 (Mus musculus) | 6480464 | propiconazole results in decreased expression of GAPVD1 mRNA | CTD | PMID:21278054 | quercetin | decreases phosphorylation | ISO | GAPVD1 (Homo sapiens) | 6480464 | Quercetin results in decreased phosphorylation of GAPVD1 protein | CTD | PMID:35688186 | rac-lactic acid | decreases expression | ISO | GAPVD1 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of GAPVD1 mRNA | CTD | PMID:30851411 | resveratrol | increases expression | ISO | Gapvd1 (Mus musculus) | 6480464 | resveratrol results in increased expression of GAPVD1 protein | CTD | PMID:25505154 | resveratrol | multiple interactions | ISO | GAPVD1 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of GAPVD1 mRNA | CTD | PMID:23557933 | sodium arsenate | decreases expression | ISO | Gapvd1 (Mus musculus) | 6480464 | sodium arsenate results in decreased expression of GAPVD1 mRNA | CTD | PMID:30953684 | sodium arsenite | affects methylation | ISO | GAPVD1 (Homo sapiens) | 6480464 | sodium arsenite affects the methylation of GAPVD1 gene | CTD | PMID:28589171 | thimerosal | decreases expression | ISO | GAPVD1 (Homo sapiens) | 6480464 | Thimerosal results in decreased expression of GAPVD1 mRNA | CTD | PMID:27188386 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of GAPVD1 mRNA | CTD | PMID:25729387 | Tributyltin oxide | decreases phosphorylation | ISO | Gapvd1 (Mus musculus) | 6480464 | bis(tri-n-butyltin)oxide results in decreased phosphorylation of GAPVD1 protein | CTD | PMID:22174045 | trichostatin A | affects expression | ISO | GAPVD1 (Homo sapiens) | 6480464 | trichostatin A affects the expression of GAPVD1 mRNA | CTD | PMID:28542535 | triptonide | increases expression | ISO | Gapvd1 (Mus musculus) | 6480464 | triptonide results in increased expression of GAPVD1 mRNA | CTD | PMID:33045310 | triptonide | affects expression | ISO | Gapvd1 (Mus musculus) | 6480464 | triptonide affects the expression of GAPVD1 mRNA | CTD | PMID:33045310 | tungsten | decreases expression | ISO | Gapvd1 (Mus musculus) | 6480464 | Tungsten results in decreased expression of GAPVD1 mRNA | CTD | PMID:30912803 | valproic acid | increases expression | ISO | GAPVD1 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of GAPVD1 mRNA | CTD | PMID:22083351 and PMID:29154799 | vinclozolin | affects expression | EXP | | 6480464 | vinclozolin affects the expression of GAPVD1 mRNA | CTD | PMID:19015723 | vorinostat | decreases expression | ISO | GAPVD1 (Homo sapiens) | 6480464 | vorinostat results in decreased expression of GAPVD1 mRNA | CTD | PMID:27188386 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
Welcome {{ username}}
Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{gene.symbol}}: {{ gene.description }}
|
| You must be logged in to use this feature |
| {{ loginError }} |
|
|
Analyze GeneStrainQTL List |
 Gene Annotator (Functional Annotation) unavailable |
 Gene Annotator (Annotation Distribution) unavailable |
 Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
 InterViewer (Protein-Protein Interactions) unavailable |
 Gviewer (Genome Viewer) unavailable |
 Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
 Gene Annotator (Annotation Comparison) unavailable |
 OLGA (Gene List Generator) unavailable |
 |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
 MOET (Multi-Ontology Enrichement) unavailable |
 GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
|
||||||||||
Gene Ontology Annotations Click to see Annotation Detail View
Biological Process
Cellular Component
Molecular Function
